Lungpacer Announces CMS NTAP Approval for AeroPace® System in FY2026 IPPS Final Rule
The AeroPace® System is an FDA-designated breakthrough device that uses periodic neurostimulation to exercise the diaphragm, helping mechanically ventilated patients to breathe independently faster. Clinical evidence shows that patients treated with the AeroPace System strengthened their diaphragm by 50%, reduced their risk of being on the ventilator for 30 days by 35%, and reduced ventilator time by 3 days when compared to standard of care.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
15 hours ago
- Toronto Star
Prime Drink Group Provides Bi-Weekly MCTO Status Report and Announces Closing of Private Placement
MONTREAL, Aug. 15, 2025 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) ('Prime' or the 'Company') announces that further to its news release date July 30, 2025, the Company voluntarily applied for and the Company's principal regulator, the British Columbia Securities Commission (the 'BCSC') granted a management cease trade order (the 'MCTO') dated July 30, 2025, under National Policy 12-203 Management Cease Trade Orders ('NP 12-203') and provided the Company with an extension to file its annual financial statements for the period ended March 31, 2025, including the related management's discussion and analysis, and related certifications on or before July 29, 2025 (collectively the 'Annual Financial Filings'). The deadline has now been extended to on or before September 29, 2025. Pursuant to the MCTO, the Chief Executive Officer and the Chief Financial Officer of the Company may not trade in securities of the Company until such time as the Company files its Annual Financial Filings on or before September 29, 2025, and the Executive Director of the BCSC revokes the MCTO. The MCTO does not affect the ability of shareholders to trade their securities.
Toronto Star
15 hours ago
- Toronto Star
First Trust Portfolios Canada Announces Cap, Buffer and Dates of August Buffer ETF
TORONTO, Aug. 15, 2025 (GLOBE NEWSWIRE) — FT Portfolios Canada Co. ('First Trust Canada'), announced today that the cap, buffer and dates for the next Target Outcome Period for the First Trust Vest U.S. Equity Buffer ETF – AUG (AUGB.F) (the 'fund' or 'August Buffer ETF') are as follows:
Toronto Star
19 hours ago
- Toronto Star
Westport Files Preliminary Short Form Base Shelf Prospectus To Replace Expired Base Shelf Prospectus
VANCOUVER, British Columbia, Aug. 15, 2025 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. ('Westport') (TSX: WPRT / Nasdaq: WPRT) announces it has filed a preliminary short form base shelf prospectus (once filed in final form and received by the relevant Canadian securities regulatory authorities, the 'Shelf Prospectus') with the securities commissions in each of the provinces and territories of Canada, to replace its prior base shelf prospectus that expired on June 18, 2025. The Shelf Prospectus, when made final, will allow Westport to offer up to USD$100,000,000 of common shares, preferred shares, subscription receipts, warrants, debt securities, or units, or any combination thereof (collectively, the 'Securities') during the 25-month period that the Shelf Prospectus will be effective. The Shelf Prospectus will enable Westport to access new capital or issue securities in connection with strategic acquisitions if and when needed. The amount and timing of any future offerings or issuances will be based on the Company's financial requirements and market conditions at that time.
